On June 28, organized by Shenzhen Biomedical Promotion Association and hosted by Shenzhen Cell Valley, the Guangdong-Hong Kong-Macao Greater Bay Area biopharmaceutical enterprise visit and exchange activity invited nearly 50 representatives of enterprises from Guangdong-Hong Kong-Macao Greater Bay Area related fields to visit Shenzhen Cell Valley. Professor Shi Yuanyuan, chairman of Shenzhen Cell Valley, Professor Wang Jianxun, chief scientist, Wei Zheng, Assistant chairman, Luan Zhishi, Director of the General Office, Sun Rui, Deputy director of Research and Development Department, and Gulina Ge Halimu, director of Marketing Department, warmly received the representatives of participating enterprises and carried out discussions and exchanges.

Under the guidance of Luan Zhishi, director of Shenzhen Cell Valley Comprehensive Office, the visiting company representatives visited the smart exhibition hall and made a preliminary explanation of the company's corporate vision, founder team, enterprise development history, CAR-T history history, service platform construction, etc.



At the symposium, Professor Shi Yuanyuan, chairman of Shenzhen Cell Valley, and Professor Wang Jianxun, chief scientist of Shenzhen Cell Valley, warmly welcomed the visiting enterprise representatives and expressed heartfelt thanks to the organizer of the event, Shenzhen Biomedicine Promotion Association. Then Sun Rui, Vice Minister of R&D Department, explained in detail the development strategy, core technology, service purpose and industry advantages of Shenzhen Cell Valley. Shi Yuanyuan, chairman of the board of Directors, said that relevant enterprises in the field of biomedinine should take advantage of this event to break through communication barriers, realize the complementary advantages of resource sharing, technology exchange and market expansion between enterprises and enterprises, and constantly promote industrial upgrading and achievement transformation.

Zhang Caiwan, vice president and secretary-general of Shenzhen Biopharmaceutical Promotion Association, said that Shenzhen Biopharmaceutical Promotion Association, as a platform for government, industry, education, research and information communication and exchange, gives full play to the role of the association as a bridge and link, and the enterprise visit and exchange activity is intended to build the Guangdong-Hong Kong-Macao Greater Bay Area biopharmaceutical related fields enterprise exchange platform construction. Strengthen the interaction between enterprises and industry experts, promote the deep integration and high-quality sustainable development of Shenzhen biomedicine industry, promote innovation and win-win cooperation.

Subsequently, the company representatives had a heated discussion on the development of the field of cell and gene therapy, platform cooperation, and the direction and ideas of jointly promoting the development of the industry. Through the communication and discussion of enterprise representatives, strategic planning and development goals are jointly formulated. As a major public service platform for Shenzhen biomedicine industry, Shenzhen Cell Valley is willing to join hands with Shenzhen Biomedicine Promotion Association to build a platform for exchanges between biomedical enterprises, academics and governments in the Guangdong-Hong Kong-Macao Greater Bay Area, and contribute to the high-quality development of biomedicine in the Guangdong-Hong Kong-Macao Greater Bay Area.